Korea Investment & Securities Decides to Prepay 70% Principal to Optimus Investors
[Asia Economy Reporter Minji Lee] Korea Investment & Securities has decided to prepay 70% of the principal to investors who suffered losses due to the suspension of redemptions of Optimus Asset Management funds.
According to the financial investment industry on the 3rd, Korea Investment & Securities held a Consumer Protection Committee meeting on the same day and decided to prepay 70% of the invested principal to investors in Optimus Asset Management funds. A company official stated, "Detailed information will be disclosed later."
Optimus Asset Management is suspected of raising thousands of billions of won from investors by claiming to invest in public institution sales bonds, but in reality, forging documents and investing in loan companies and insolvent firms.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- Individual Investors Absorb Foreign Sell-Off... Concerns Over Becoming "Cannon Fodder" Emerge
- Experts Shocked by Record Numbers: "Just the Tip of the Iceberg" — The Identity Behind the 90% Dominating Teens [Chuiyakgukga]⑨
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
Meanwhile, NH Investment & Securities, another distributor of Optimus funds, met with the emergency response committee of the victims' group the previous day and expressed its commitment to prepare compensation measures and do its best to recover customer assets.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Cheaper Than Mychew, but Nowhere to Be Found... Fears of a 'Pediatric Medical Crisis' as Drug Makers Halt Production [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/307/2026051910065268365_1779152813.jpg)
